IgE-Mediated Immune Response and Antibody-Mediated Rejection

Area of Science:

• Immunology
• Transplantation Science
• Nephrology

Background:

• Active antibody-mediated rejection (AMR) is a primary cause of kidney transplant failure.
• Both AMR and Systemic Lupus Erythematosus (SLE) involve alloimmune responses and interferon-alpha (IFN-α) pathway activation.
• IgE-mediated immune responses are implicated in SLE nephritis and IFN-α secretion.

Purpose of the Study:

• To investigate the role of IgE-mediated immune responses in antibody-mediated rejection of kidney transplants.

Main Methods:

• Cross-sectional study involving 56 kidney transplant recipients with AMR, 80 controls, 16 with interstitial fibrosis/tubular atrophy, and 6 with SLE.
• Immunofluorescence/confocal microscopy to assess graft IgE deposition, mast cells (tryptase), and activated basophils (CD203).
• Serum analysis for IFN-α-induced protein MxA and anti-HLA IgE antibodies.

Main Results:

• Significantly higher IgE deposition observed in tubules and glomeruli in AMR and SLE groups compared to controls and fibrosis/atrophy groups.
• Circulating anti-HLA IgE antibodies were present in AMR patients, alongside mast cells and activated basophils in the grafts.
• Elevated serum MxA levels in AMR correlated with IgE deposition, indicating IFN-α pathway activation.

Conclusions:

• IgE deposition within kidney transplants is associated with antibody-mediated rejection.
• Recruitment of mast cells and basophils, potentially driven by IgE, may contribute to AMR pathogenesis.
• These findings highlight a potential IgE-mediated mechanism in kidney transplant rejection.